论文部分内容阅读
髓母细胞瘤(MB)好发生于儿童,约占儿童脑肿瘤的17.7%,3岁以下者占儿童MB的25%~30%。MB的恶性程度较高,单纯手术不易完全切除,但MB对放疗、化疗多较敏感。目前标准治疗方案是进行手术,然后接受放疗和化疗。近年来,许多研究者对术后放疗、化疗的方案进行了大量研究,希望能够在保证较好疗效的前提下,减少患者不良反应。现就近年来术后放疗、化疗方案的研究进展进行综述。
Myeloblastoma (MB) occurs well in children, accounting for about 17.7% of children with brain tumors, children under 3 years of age accounted for 25% of children MB 30%. MB is more malignant, simple surgery is not easy to completely resected, but MB is more sensitive to radiotherapy and chemotherapy. The current standard treatment is surgery, and then receive radiotherapy and chemotherapy. In recent years, many researchers have done a lot of researches on the scheme of postoperative radiotherapy and chemotherapy, hoping to reduce the patients’ adverse reactions under the premise of ensuring good curative effect. Now in recent years, postoperative radiotherapy, chemotherapy programs are reviewed.